Speculum - University of Melbourne
Speculum - University of Melbourne
Speculum - University of Melbourne
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
48 SPECULUM<br />
ReJearch . . .<br />
". . . . to merit and preserve the<br />
confidence <strong>of</strong> the best element<br />
in the medical and pharmaceutical<br />
pr<strong>of</strong>essions . . . . to build<br />
well, to last."<br />
It was in these words that, over 90 years ago, the<br />
founders <strong>of</strong> the House <strong>of</strong> Parke-Davis expressed their<br />
policy for the future.<br />
To meet these self-imposed and exacting demands,<br />
research has been a constant feature <strong>of</strong> the Company's<br />
activities. Over the years many contributions to Medicine<br />
have resulted: vegetable drugs such as Cascara<br />
Sagrada; glandular products, including Adrenalin, Pituitrin,<br />
Pitocin, Pitressin, Antuitrin "S" and Eschatin; vitamin<br />
preparations; and many synthetic chemicals such<br />
as Dilantin. Recent achievements include the antihistamines,<br />
Benadryl and Ambodryl, and the first synthetic<br />
antibiotic, Chloromycetin.<br />
Today, backed by a research programme more extensive<br />
than ever before, Parke-Davis <strong>of</strong>fer the medical pr<strong>of</strong>ession<br />
products worthy <strong>of</strong> their symbol, "Medicamenta<br />
Vera"—truth in medicine.<br />
PARKE, DAVIS & CO., LTD.<br />
(Lnc.<br />
BOX 4198, SYDNEY